Navigation Links
Medicine: The heart's metronome
Date:11/12/2013

A specific cell population is responsible for ensuring that our heartbeat remains regular. Researchers from Ludwig-Maximilians-Universitaet (LMU) in Munich have now elucidated the mode of action of one of the crucial components of the heart's intrinsic pacemaker.

The heart possesses a pacemaker of its very own. Specialized pacemaker cells in the so-called sinoatrial node in the left ventricle of the heart control its rate of contraction and relaxation by orchestrating a recurring sequence of electrical signals. Specific proteins known as HCN channels, which are located in the surface membranes of pacemaker cells, play a central role in the generation and transmission of these signals. These proteins function as pores for the passage of electrically charged atoms (ions) across the cell membrane. Because the pore diameter can be regulated, the channels can control the flow of ions across the membrane, and thus determine the difference in electrical potential between the inner and outer surfaces of the cell. Cyclical changes in this parameter give rise to autonomously generated, rhythmic electrical impulses that dictate heartbeat and cardiac rhythmicity.

HCN channels are found primarily in the heart and in the brain, and come in four subtypes, HCN1-4. HCN4 is responsible for about 80% of the total ion current that passes through HCN channels in the sinoatrial node. The other 20% is carried by HCN1 and HCN2. "But while the functions of HCN2 and HCN4 in the sinoatrial node have been extensively studied, the impact of HCN1 on heart rate has so far remained unknown," says Professor Christian Wahl-Schott of the Department of Pharmacy at LMU, who has now closed this gap in our knowledge of the heart's intrinsic pacemaker.

Wahl-Schott and his team and also researchers from Professor Martin Biel's group, tackled the problem by using a mouse strain in which the HCN1 channels in the cells of the sino-atrial node are defective. With the aid of this new experimental model, they were able to demonstrate, for the first time, that HCN1 is involved not in generating the electrical impulse but also in its propagation within the node. Defects in HCN1 function compromise the normal operation of the pacemaker. This results in bradycardia a pathological reduction in heart rate and increases the incidence of arrhythmias. As a consequence, overall cardiac output is significantly reduced. "We were also able to confirm these effects in vivo by means of telemetric electrocardiography," Wahl-Schott adds.

Defects in cells of the sino-atrial node are associated with sudden cardiac arrest, and more than half of all implantations of artificial pacemakers worldwide are carried out on patients who suffer from such conditions. But the new findings regarding the role of HCN1 in the regulation of heart function are actually of clinical interest for two reasons. On the one hand, this channel subtype offers a promising target for drugs designed to normalize heartbeat frequency. However, HCN1 is also found in nerve cells in the brain, where it likewise acts to control rates of neural firing. This explains why HCN1 blockers are under consideration for use in the treatment of epilepsy, chronic pain and depression. "In light of our results, the potential effects of HCN1 blockers on cardiac function should be carefully assessed before such agents are used in other contexts," Wahl-Schott warns.


'/>"/>

Contact: Luise Dirscherl
dirscherl@lmu.de
49-892-180-2706
Ludwig-Maximilians-Universitt Mnchen
Source:Eurekalert

Related medicine news :

1. The Khalili Center for Bariatric Care Seconds the Findings of The New England Journal of Medicine: Surgical Skills Are Essential
2. Study in New England Journal of Medicine: Colonoscopy saves lives
3. Treating Allergies with Traditional Medicine: Ayurvedic Medicine During the Spring Season 2013
4. Ancient Native Remedy: Healing with Clay prescribed as Powerful Medicine: Zion Health's Clay Bath Detox Minerals now Available at Weaver’s Way Co-op in Philadelphia
5. Austin Sports Medicine: Post-Race Recovery Tips from Medicine in Motion
6. Austin Sports Medicine: Race Day Tips from Medicine in Motion
7. Regenerative medicine: Clinical trials launched for the treatment of delayed union fractures
8. Personalizing medicine: New American Chemical Society Prized Science video
9. Molecular Genetics & Genomic Medicine: New open access journal launched by Wiley
10. Applied nanobiomedicine: Exploiting nanoparticles to hunt for hidden cancer cells
11. Clotting protein hardens aging hearts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... CA (PRWEB) , ... June 25, 2016 , ... As ... with Magna Cum Laude and his M.D from the David Geffen School of Medicine ... and returned to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June 14 ... The article goes on to state that individuals are now more comfortable seeking to ... operations such as calf and cheek reduction. The Los Angeles area medical group, Beverly ...
(Date:6/24/2016)... Texas (PRWEB) , ... June 24, 2016 , ... ... International Conference and Scientific Sessions in Dallas that it will receive two significant ... of the grants came as PHA marked its 25th anniversary by recognizing patients, ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway ... call for a minimum wage raise to $12 an hour by 2020 and then adjusting ... restore the lost value of the minimum wage, assure the wage floor does not erode ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Grove Investment Group (TGIG), has initiated cultivation and processing operations at its production ... and Pahrump, Nevada. , Puradigm is the manufacturer of a complete system of ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Research and Markets has announced the addition of ... report to their offering. ... The World Market for Companion Diagnostics covers the world market ... the report includes the following: , World ... Region (N. America, EU, ROW), 2015-2020 , World IVD ...
(Date:6/24/2016)... Tenn. , June 24, 2016  Arkis ... providing less invasive and more durable cerebrospinal fluid ... in funding.  The Series-A funding is led by ... Lighthouse Fund, and other private investors.  Arkis, new ... neurosurgical instrumentation and the market release of its ...
(Date:6/23/2016)... Research and Markets has announced ... Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality ... - Global Forecast to 2021" report to their ... global pharmaceutical excipients market is projected to reach USD ... in the forecast period 2016 to 2021. ...
Breaking Medicine Technology: